632 related articles for article (PubMed ID: 20889126)
1. Insulin signaling to the glomerular podocyte is critical for normal kidney function.
Welsh GI; Hale LJ; Eremina V; Jeansson M; Maezawa Y; Lennon R; Pons DA; Owen RJ; Satchell SC; Miles MJ; Caunt CJ; McArdle CA; Pavenstädt H; Tavaré JM; Herzenberg AM; Kahn CR; Mathieson PW; Quaggin SE; Saleem MA; Coward RJM
Cell Metab; 2010 Oct; 12(4):329-340. PubMed ID: 20889126
[TBL] [Abstract][Full Text] [Related]
2. Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor.
Lay AC; Hurcombe JA; Betin VMS; Barrington F; Rollason R; Ni L; Gillam L; Pearson GME; Østergaard MV; Hamidi H; Lennon R; Welsh GI; Coward RJM
Diabetologia; 2017 Nov; 60(11):2299-2311. PubMed ID: 28852804
[TBL] [Abstract][Full Text] [Related]
3. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
[No Abstract] [Full Text] [Related]
4. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
5. Podocytes, glucose and insulin.
Welsh GI; Coward RJ
Curr Opin Nephrol Hypertens; 2010 Jul; 19(4):379-84. PubMed ID: 20539231
[TBL] [Abstract][Full Text] [Related]
6. Persistent Insulin Resistance in Podocytes Caused by Epigenetic Changes of SHP-1 in Diabetes.
Lizotte F; Denhez B; Guay A; Gévry N; Côté AM; Geraldes P
Diabetes; 2016 Dec; 65(12):3705-3717. PubMed ID: 27585521
[TBL] [Abstract][Full Text] [Related]
7. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy.
Denhez B; Rousseau M; Dancosst DA; Lizotte F; Guay A; Auger-Messier M; Côté AM; Geraldes P
Diabetes; 2019 May; 68(5):1026-1039. PubMed ID: 30862678
[TBL] [Abstract][Full Text] [Related]
8. Proteinuria, the podocyte, and insulin resistance.
Fornoni A
N Engl J Med; 2010 Nov; 363(21):2068-9. PubMed ID: 21083394
[No Abstract] [Full Text] [Related]
9. Podocytes as a target of insulin.
Coward RJ; Saleem MA
Curr Diabetes Rev; 2011 Jan; 7(1):22-7. PubMed ID: 21067503
[TBL] [Abstract][Full Text] [Related]
10. A role for NPY-NPY2R signaling in albuminuric kidney disease.
Lay AC; Barrington AF; Hurcombe JA; Ramnath RD; Graham M; Lewis PA; Wilson MC; Heesom KJ; Butler MJ; Perrett RM; Neal CR; Herbert E; Mountjoy E; Atan D; Nair V; Ju W; Nelson RG; Kretzler M; Satchell SC; McArdle CA; Welsh GI; Coward RJM
Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15862-15873. PubMed ID: 32561647
[TBL] [Abstract][Full Text] [Related]
11. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
12. IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes.
Santamaria B; Marquez E; Lay A; Carew RM; González-Rodríguez Á; Welsh GI; Ni L; Hale LJ; Ortiz A; Saleem MA; Brazil DP; Coward RJ; Valverde ÁM
Biochim Biophys Acta; 2015 Dec; 1853(12):3224-34. PubMed ID: 26384875
[TBL] [Abstract][Full Text] [Related]
13. Podocyte EGFR Inhibits Autophagy Through Upregulation of Rubicon in Type 2 Diabetic Nephropathy.
Li Y; Pan Y; Cao S; Sasaki K; Wang Y; Niu A; Fan X; Wang S; Zhang MZ; Harris RC
Diabetes; 2021 Feb; 70(2):562-576. PubMed ID: 33239448
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy.
Barutta F; Bellini S; Kimura S; Hase K; Corbetta B; Corbelli A; Fiordaliso F; Bruno S; Biancone L; Barreca A; Papotti MG; Hirsh E; Martini M; Gambino R; Durazzo M; Ohno H; Gruden G
Autophagy; 2023 Feb; 19(2):505-524. PubMed ID: 35659195
[TBL] [Abstract][Full Text] [Related]
15. Podocytes, signaling pathways, and vascular factors in diabetic kidney disease.
Brosius FC; Coward RJ
Adv Chronic Kidney Dis; 2014 May; 21(3):304-10. PubMed ID: 24780459
[TBL] [Abstract][Full Text] [Related]
16. The insulin receptor and the kidney.
Hale LJ; Coward RJ
Curr Opin Nephrol Hypertens; 2013 Jan; 22(1):100-6. PubMed ID: 23104093
[TBL] [Abstract][Full Text] [Related]
17. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice.
Gödel M; Hartleben B; Herbach N; Liu S; Zschiedrich S; Lu S; Debreczeni-Mór A; Lindenmeyer MT; Rastaldi MP; Hartleben G; Wiech T; Fornoni A; Nelson RG; Kretzler M; Wanke R; Pavenstädt H; Kerjaschki D; Cohen CD; Hall MN; Rüegg MA; Inoki K; Walz G; Huber TB
J Clin Invest; 2011 Jun; 121(6):2197-209. PubMed ID: 21606591
[TBL] [Abstract][Full Text] [Related]
18. Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy.
Madhusudhan T; Wang H; Dong W; Ghosh S; Bock F; Thangapandi VR; Ranjan S; Wolter J; Kohli S; Shahzad K; Heidel F; Krueger M; Schwenger V; Moeller MJ; Kalinski T; Reiser J; Chavakis T; Isermann B
Nat Commun; 2015 Mar; 6():6496. PubMed ID: 25754093
[TBL] [Abstract][Full Text] [Related]
19. Role of Ragulator in the Regulation of Mechanistic Target of Rapamycin Signaling in Podocytes and Glomerular Function.
Yao Y; Wang J; Yoshida S; Nada S; Okada M; Inoki K
J Am Soc Nephrol; 2016 Dec; 27(12):3653-3665. PubMed ID: 27032892
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of IRAK1 attenuates podocyte apoptosis in diabetic nephropathy through PI3K/Akt signaling pathway.
Zhang Y; Chen X; Yuan L; Zhang Y; Wu J; Guo N; Chen X; Liu J
Biochem Biophys Res Commun; 2018 Nov; 506(3):529-535. PubMed ID: 30361091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
